SDT

MagicCube Partners with Shift4 to Offer Android Tap-to-Pay Solution

Retrieved on: 
Sunday, January 14, 2024
SDT, Sales management, Apple Pay, NRF, Samsung Pay, Android, Samsung, Google Pay, PIN, Tablet, System, Commerce, PCI, Online shopping

SANTA CLARA, Calif., Jan. 14, 2024 /PRNewswire/ -- MagicCube, the startup that created the Software Defined Trust (SDT) category, announced today at NRF's Retail Big Show that it has partnered with Shift4 (NYSE: FOUR), the leader in integrated payments and commerce technology, to offer the company's i-Accept™ solution to merchants in the United States. i-Accept turns any Android smartphone or tablet into a PCI compliant payment device that can accept secure contactless payments using Tap-to-Pay – with or without PIN.

Key Points: 
  • i-Accept turns any Android smartphone or tablet into a PCI compliant payment device that can accept secure contactless payments using Tap-to-Pay – with or without PIN.
  • "At Shift4, our mission is to power commerce by empowering merchants with simple and innovative technology solutions," said Michael Isaacman, Chief Commercial Officer at Shift4.
  • "MagicCube's state-of-the-art i-Accept solution aligns with this goal by delivering unmatched flexibility and convenience for retail businesses of all types and sizes."
  • To learn more, visit www.i-accept.com or visit the Shift4 booth at NRF's Retail Big Show, in New York City, January 14-16.

SonALAsense Presents Preliminary Data From Clinical Study in Patients With Deadly Pediatric Brain Tumor

Retrieved on: 
Wednesday, December 13, 2023
Surgery, Medical Devices, Neurology, Clinical Trials, Biotechnology, Radiology, Health, Pharmaceutical, Oncology, SDT, Radiation, Hope, Pakistan Society of Neuro-Oncology, Sonodynamic therapy, Patient, Aminolevulinic acid, Death, Diffusion, Steroid, Incisionless Fritsch otoplasty, Neurosurgery, Hydrogen chloride, Diagnosis, Survival, Diffuse intrinsic pontine glioma, Infrared spectroscopy correlation table, Quality of life, DIPG, SNO, Metastasis, Medical imaging, Pharmaceutical industry, Development

These results were presented at the November 2023 Society for Neuro-Oncology (SNO) Annual Meeting in Vancouver, Canada.

Key Points: 
  • These results were presented at the November 2023 Society for Neuro-Oncology (SNO) Annual Meeting in Vancouver, Canada.
  • The preliminary data from Study SDT-201 shows signals of clinical activity and no safety concerns.
  • Study SDT-201 is a dose escalation and expansion study in patients with DIPG.
  • Six (6) patients have been treated to date and dose escalation is ongoing.

FDA Grants Fast Track Designation to SonALAsense’s SONALA-001 in Combination with the INSIGHTEC Transcranial Ultrasound Device for Sonodynamic Therapy of DIPG, a Rare Pediatric Brain Cancer

Retrieved on: 
Tuesday, November 14, 2023
Oncology, Health, FDA, Medical Devices, Neurology, Clinical Trials, Biotechnology, Brain, SDT, Safety, Annual general meeting, Radiation, ALA, Pons, Pakistan Society of Neuro-Oncology, Plasma protein binding, Collection, Sonodynamic therapy, Patient, Heart rate, Light, NCT, Hydrogen chloride, Diffuse intrinsic pontine glioma, Survival, Diagnosis, Trial of the century, Communication, Biomarker, DIPG, SNO, Spinal cord, Blood pressure, Pharmaceutical industry, Development

This builds upon SONALA-001 also having received orphan drug designation in 2021 for malignant gliomas.

Key Points: 
  • This builds upon SONALA-001 also having received orphan drug designation in 2021 for malignant gliomas.
  • The FDA’s Fast Track is a process designed to facilitate the development, and expedited review, of drugs to treat serious conditions and fill an unmet medical need.
  • “Receiving Fast Track Designation underscores the immediate and urgent need to bring new therapy options for DIPG patients,” said Ely Benaim, M.D., SonALAsense’s Chief Medical Officer and Executive Vice President of Development.
  • Approximately 300 children are diagnosed with DIPG each year in the US, usually between the ages of 5 and 9.

SmartDisplayer Taiwan Introduces FIDO L1 & L2 Certified BobeePass FIDO 2nd Gen Card, Redefining Secure Access Control with its Card-Shaped Design

Retrieved on: 
Wednesday, July 26, 2023
Multimedia, Fingerprint, FPS, Mastercard, News, SDT, L2, Online shopping, Visa

BobeePass Card offers unparalleled versatility and compatibility, making it an excellent choice for those seeking a secure and reliable access control solution.

Key Points: 
  • BobeePass Card offers unparalleled versatility and compatibility, making it an excellent choice for those seeking a secure and reliable access control solution.
  • The BobeePass Card is FIDO L1 and L2 certified, ensuring stringent security measures and catering to specific application scenarios.
  • SmartDisplayer Taiwan continues to set new benchmarks in secure access control solutions, and the launch of the BobeePass Card further strengthens its commitment to providing a reliable and sophisticated access control solution.
  • With its card-shaped design, advanced security features, and versatile functionality, the BobeePass Card is poised to revolutionize access control across various industries and settings.

BERNINA of America Unveils Three Innovative Sewing, Embroidery and Quilting Machines That Celebrate Creativity and Precision

Retrieved on: 
Tuesday, June 27, 2023
Heart, Human, Yaya, Creative consultant, Pinterest, Yara Bernette, MSRP, Kaffe, Smartphone, PRO, Wi-Fi, Kaffe Fassett, Blog, Creativity, Creative, Multi, Stitch, Imagination, BSR, SDT, Memory, Limited Edition, Bookbinding, Sewing, Cryptocurrency, Telescopic sight, Carpet, Lace

BERNINA 790 PRO --- Preorders available starting June 27, 2023. MSRP is $15,499.00

Key Points: 
  • BERNINA of America , the premier manufacturer of sewing, embroidery and quilting machines, is unveiling three revolutionary new machines to further enhance the joy of creating.
  • They will further enhance the quality and Swiss precision sewing enthusiasts have come to expect from BERNINA,” said Paul Ashworth, CEO and President, BERNINA of America.
  • “I couldn’t be more excited about the cutting-edge technology of the B 790 PRO sewing, embroidery and quilting machine.
  • MSRP is $15,499.00
    The next generation sewing, embroidery and quilting machine is enriched with BERNINA stitchprecision² technology that makes the creative experience more precise and joyful.

SonALAsense Welcomes Dr. Ely Benaim as Chief Medical Officer and Executive Vice President of Development

Retrieved on: 
Tuesday, May 9, 2023
Science, Neurology, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Data management, Amgen, Drug development, Diffuse intrinsic pontine glioma, Jude the Apostle, History, Doctor of Philosophy, Glioblastoma, High-intensity focused ultrasound, DIPG, Journal, Patient, ALA, Reactive oxygen species, Takeda Oncology, Journal of Neuro-Oncology, Decompression (diving), Sonodynamic therapy, Aminolevulinic acid, FDA, SDT, Safety, Medical imaging, Nursing, Pharmaceutical industry, Medical device, Development

SonALAsense, a pioneer in the development of non-invasive Sonodynamic Therapy (SDT) using SONALA-001 in combination with Insightec’s MR-guided focused ultrasound (MRgFUS), has appointed Ely Benaim, M.D., as Chief Medical Officer and Executive Vice President of Development.

Key Points: 
  • SonALAsense, a pioneer in the development of non-invasive Sonodynamic Therapy (SDT) using SONALA-001 in combination with Insightec’s MR-guided focused ultrasound (MRgFUS), has appointed Ely Benaim, M.D., as Chief Medical Officer and Executive Vice President of Development.
  • Benaim brings decades of clinical and industry experience and incredible insights to SonALAsense,” said Mark de Souza, PhD, Chief Executive Officer at SonALAsense.
  • Later, he moved into drug development, taking high-profile positions at Amgen, Sangamo BioSciences, Millennium Pharmaceuticals, Rexahn Pharmaceuticals and others.
  • Prior to joining SonALAsense, he was Chief Medical Officer for Novocure, where he managed several pivotal clinical trials.

SonALAsense Announces Completion of First Cohort in Phase 2 Study of SONALA-001 Sonodynamic Therapy for Recurrent Glioblastoma

Retrieved on: 
Wednesday, March 8, 2023
Biotechnology, Health, Radiology, Pharmaceutical, Oncology, Health Technology, Medical Devices, Research, Surgery, Science, Clinical Trials, ALA, NYU, Learning, High-intensity focused ultrasound, Brain, Cell death, Light, Patient, Sonodynamic therapy, ABTA, American Brain Tumor Association, Cleveland Clinic, University of California, San Francisco, Mayo Clinic, Clinical trial, Radiation, Monroe Dunaway Anderson, Decompression (diving), Oxidative stress, Quality of life, Barrow Neurological Institute, Glioblastoma, SDT, POC, University, Aminolevulinic acid, Doctor of Philosophy, Cleveland, Safety, Medical imaging, Medical device, MD

SDT-202 is an open-label, dose-escalation trial of SDT in recurrent glioblastoma (rGBM).

Key Points: 
  • SDT-202 is an open-label, dose-escalation trial of SDT in recurrent glioblastoma (rGBM).
  • The first cohort in SDT-202 was enrolled at Cleveland Clinic by principal investigator Matthew Grabowski, MD.
  • “At SonALAsense, we are excited to further develop SONALA-001 SDT as a potential approach to treat this devastating brain cancer.
  • “We look forward to the outcomes of this clinical trial and learning more about the potential benefits of sonodynamic therapy.”

BERNINA of America Celebrates National Embroidery Month this February With Biggest Deals of the Year on Embroidery Machines and Accessories

Retrieved on: 
Thursday, February 16, 2023
PLUS, SDT, DECO, MSRP, Bernette Ford, FREE, Toolbox, Module, Heart, Clothing, Sewing

AURORA, Ill., Feb. 16, 2023 (GLOBE NEWSWIRE) -- February is National Embroidery Month and BERNINA of America is celebrating with promotions on embroidery machines sure to make sewing enthusiasts swoon.

Key Points: 
  • AURORA, Ill., Feb. 16, 2023 (GLOBE NEWSWIRE) -- February is National Embroidery Month and BERNINA of America is celebrating with promotions on embroidery machines sure to make sewing enthusiasts swoon.
  • Specifically for embroidery fans there is the B 700 embroidery machine whose embroidery module is interchangeable with all BERNINA 7 & 8 Series machines.
  • BERNINA 5 SERIES: The BERNINA 5 Series is designed for ambitious creatives who enjoy sewing, crafting, quilting and embroidery projects.
  • The BERNINA 5 Series is an extraordinary line of mid-size sewing, quilting and embroidery machines that also feature the BERNINA Hook and the Jumbo Bobbin.

Administrators Report Roughly Half of Public School Students Began 2022-23 School Year Behind Grade Level in At Least One Academic Subject

Retrieved on: 
Thursday, February 9, 2023
National Center for Education Statistics, HDT, PD, SDT, U.S. Department of Education, Office of Inspector General, Mathematics, United States Secretary of Education, Education sciences, Quarantine, Research, School, Privacy Office of the U.S. Department of Homeland Security, Parent, Student, Policy, Curriculum, IES, NCES, Learning, Prevalence, COVID-19, SPT, Tutoring, Management, Education

WASHINGTON, Feb. 9, 2023 /PRNewswire/ -- Public school leaders estimated that about half—49 percent—of their students began the 2022-23 year behind grade level in at least one academic subject, according to data released today by the National Center for Education Statistics (NCES), the statistical center within the U.S. Department of Education's Institute of Education Sciences (IES). Almost all public schools with students behind grade level in at least one academic subject reported that at least some students were behind grade level in English or mathematics. 

Key Points: 
  • Almost all public schools with students behind grade level in at least one academic subject reported that at least some students were behind grade level in English or mathematics.
  • "Both this school year and last school year, public school leaders estimated that about half of their students began the school year behind grade level in at least one academic subject.
  • In addition to the strategies mentioned above, most public schools provide some type of tutoring to their students (83 percent).
  • Entering the 2022-23 school year, public schools estimated that, on average, 49 percent of their students began the year behind grade level in at least one academic subject.

MicroCloud Hologram (NASDAQ: HOLO) Develops 3D-BIM Blockchain NFT Technology

Retrieved on: 
Thursday, February 2, 2023
Blockchain, SDT, InterPlanetary File System, IPFS, Research, Bionics, Drawing, Data management, NFT, 3D, Cryptocurrency

BEIJING, Feb. 2, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced its development of a 3D-BIM multi-user collaborative design solution based on blockchain NFT technology.

Key Points: 
  • BEIJING, Feb. 2, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced its development of a 3D-BIM multi-user collaborative design solution based on blockchain NFT technology.
  • HOLO applies blockchain NFT technology to achieve highly reliable and traceable data management through the distributed ledger and consensus mechanism.
  • HOLO has built a repository of holographic digital twins based on blockchain NFT technology, which holographic developers and designers rely on.
  • HOLO provides customized holographic digital technology integration services based on blockchain NFT technology for corporate clients with tailored business needs.